Skip to Main Content


STAT’s coverage roundup of substance abuse, addiction treatment centers, and the nation’s overdose crisis. Stories on this page include insurance coverage for naloxone, doctor wariness on buprenorphine, and multiple angles on the opioid crisis.

Other articles include Purdue Pharmaceutical’s controversial bankruptcy,  new definitions of recovery, and new data on addiction treatment. You’ll find stories on Xylazine, also known as Tranq, fentanyl, and oxycontin, and you’ll find an essay in defense of what’s known as “California sober.”

All Coverage